What is the contribution of obesity to the metabolic syndrome?

被引:63
作者
Grundy, SM
机构
[1] Univ Texas, SW Med Ctr Dallas, Ctr Human Nutr, Dept Clin Nutr, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr Dallas, Ctr Human Nutr, Dept Internal Med, Dallas, TX 75390 USA
关键词
D O I
10.1016/j.ecl.2004.03.001
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Many prospective studies show that obesity is accompanied by increased risk for cardiovascular disease. Obesity affects metabolism of lipids and glucose, regulation of blood pressure, thrombotic and fibrinolytic processes, and inflammatory reactions. Multiple aberrations exist in each of these systems; obesity acting alone probably is not sufficient to produce full-blown metabolic syndrome. There must be other factors, including genetic and aging factors. It is difficult to sort out all pathogenic factors that link obesity to cardiovascular disease risk. It is worthwhile to investigate individually the components of the obesity-induced metabolic syndrome for their atherogenic potential, because out of that investigation likely will come new targets for clinical or public health intervention to reduce the risk for cardiovascular disease.
引用
收藏
页码:267 / +
页数:17
相关论文
共 74 条
[51]
Nie LC, 1998, J LIPID RES, V39, P1127
[52]
OLEFSKY JM, 1977, J LIPID RES, V18, P459
[53]
Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients [J].
Paquot, N ;
Scheen, AJ ;
Dirlewanger, M ;
Lefèbvre, PJ ;
Tappy, L .
OBESITY RESEARCH, 2002, 10 (03) :129-134
[54]
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus [J].
Pradhan, AD ;
Manson, JE ;
Rifai, N ;
Buring, JE ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (03) :327-334
[55]
Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up [J].
Qiao, Q ;
Jousilahti, P ;
Eriksson, J ;
Tuomilehto, J .
DIABETES CARE, 2003, 26 (10) :2910-2914
[56]
RANDLE PJ, 1963, LANCET, V1, P785
[57]
ROLE OF INSULIN RESISTANCE IN HUMAN-DISEASE [J].
REAVEN, GM .
DIABETES, 1988, 37 (12) :1595-1607
[58]
MULTIPLE LIPOLYSIS DEFECTS IN THE INSULIN-RESISTANCE (METABOLIC) SYNDROME [J].
REYNISDOTTIR, S ;
ELLERFELDT, K ;
WAHRENBERG, H ;
LITHELL, H ;
ARNER, P .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) :2590-2599
[59]
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events [J].
Ridker, PM ;
Buring, JE ;
Cook, NR ;
Rifai, N .
CIRCULATION, 2003, 107 (03) :391-397
[60]
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men [J].
Ridker, PM ;
Rifai, N ;
Stampfer, MJ ;
Hennekens, CH .
CIRCULATION, 2000, 101 (15) :1767-1772